MGAM, meanwhile, is involved in biological processes related to oxidative stress and inflammation and has been proposed as a potential diagnostic and prognostic biomarker for patients with pain-depression comorbidity (34). The gene discussed is MGAM; the disease is depressive symptom measurement.